Form 13-F position report

INTEGRA LIFESCIENCES HLDGS C

Reported by STATE STREET CORPORATION

IART CUSIP 457985208 Manager CIK 0000093751

Reported 2,946,862 shares, up 60,306 (2.1%) from the prior quarter.

Reported value 94.6%; share count 2.1% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q2 2026
Shares 2,946,862 Quarter-end amount reported
Reported value $52,925,642 Fair value at quarter end
Consecutive quarters held 53 Through Q2 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 131239000
2022-03-31 128849000
2022-06-30 106715000
2022-09-30 86526000
2022-12-31 117967692
2023-03-31 124406551
2023-06-30 91210094
2023-09-30 81633455
2023-12-31 92141653
2024-03-31 75095047
2024-06-30 80990638
2024-09-30 51353053
2024-12-31 64704158
2025-03-31 60416030
2025-06-30 34680726
2025-09-30 39993568
2025-12-31 34932678
2026-03-31 27191358
2026-06-30 52925642
2026-09-30 49162637

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for INTEGRA LIFESCIENCES HLDGS C held by STATE STREET CORPORATION.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 3,019,818 +72,956 (2.5%) < 0.01% $49,162,637 2026-11-12
Q2 2026 Added 2,946,862 +60,306 (2.1%) < 0.01% $52,925,642 2026-08-07
Q1 2026 Added 2,886,556 +73,941 (2.6%) < 0.01% $27,191,358 2026-05-15
Q4 2025 Added 2,812,615 +21,717 (0.8%) < 0.01% $34,932,678 2026-02-13
Q3 2025 Reduced 2,790,898 -35,567 (-1.3%) < 0.01% $39,993,568 2025-11-14
Q2 2025 Added 2,826,465 +79,033 (2.9%) < 0.01% $34,680,726 2025-08-14
Q1 2025 Reduced 2,747,432 -105,485 (-3.7%) < 0.01% $60,416,030 2025-05-15
Q4 2024 Added 2,852,917 +26,662 (0.9%) < 0.01% $64,704,158 2025-02-14
Q3 2024 Added 2,826,255 +46,892 (1.7%) < 0.01% $51,353,053 2024-11-14
Q2 2024 Added 2,779,363 +661,026 (31.2%) < 0.01% $80,990,638 2024-08-14
Q1 2024 Added 2,118,337 +2,570 (0.1%) < 0.01% $75,095,047 2024-05-15
Q4 2023 Reduced 2,115,767 -21,794 (-1.0%) < 0.01% $92,141,653 2024-02-14
Q3 2023 Reduced 2,137,561 -80,044 (-3.6%) < 0.01% $81,633,455 2023-11-14
Q2 2023 Added 2,217,605 +50,621 (2.3%) < 0.01% $91,210,094 2023-08-14
Q1 2023 Added 2,166,984 +63,048 (3.0%) < 0.01% $124,406,551 2023-05-15
Q4 2022 Added 2,103,936 +61,296 (3.0%) < 0.01% $117,967,692 2023-02-14
Q3 2022 Added 2,042,640 +67,534 (3.4%) < 0.01% $86,526,000 2022-11-15
Q2 2022 Reduced 1,975,106 -30,021 (-1.5%) < 0.01% $106,715,000 2022-08-15
Q1 2022 Added 2,005,127 +46,038 (2.3%) < 0.01% $128,849,000 2022-05-16
Q4 2021 Added 1,959,089 +33,341 (1.7%) < 0.01% $131,239,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

245 managers reported INTEGRA LIFESCIENCES HLDGS C for Q2 2026.

Managers reporting INTEGRA LIFESCIENCES HLDGS C in Q2 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 10,684,103 +364,934 < 0.01% $191,886,488 8 qtrs
Rubric Capital Management LP Unchanged 7,753,934 0 1.28% $139,260,655 8 qtrs
Invesco Ltd Added 3,749,367 +263,764 < 0.01% $67,338,631 53 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Added 3,743,093 +56,456 < 0.01% $67,225,950 2 qtrs
MORGAN STANLEY Added 3,593,079 +8,924 < 0.01% $64,531,722 53 qtrs
PARADIGM CAPITAL MANAGEMENT INC NY Reduced 3,439,098 -573,600 1.68% $61,766,200 8 qtrs
FULLER & THALER ASSET MANAGEMENT INC Reduced 3,436,006 -93,398 0.17% $61,710,664 29 qtrs
STATE STREET CORPORATION This report Added 2,946,862 +60,306 < 0.01% $52,925,642 53 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 2,946,173 +55,349 < 0.01% $52,913,267 2 qtrs
Neuberger Berman Group LLC Added 2,364,777 +249,522 0.03% $42,626,533 15 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2026
Filed
August 07, 2026
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
397,386
Shared
574
None
2,548,902

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.